Client Alert: The Supreme Court Signals That Access to Mifepristone Will Likely Remain Safe for Now

Start
On March 26, 2024, the Supreme Court heard arguments in the two consolidated cases concerning access to mifepristone pending before the Court, FDA v. Alliance for Hippocratic Medicine, Case No. 23-235 and Danco Laboratories, LLC v. Alliance for Hippocratic Medicine, Case No. 23-236……
By: Jenner & Block
Previous Story

Paid in Full: GSA Approves Advance Payment for SaaS Licenses

Next Story

Medicare Coverage of Wegovy Raises Questions Regarding the Affordability and Accessibility of Novel Medications